Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA2280 GRL-0496Summary: GRL-0496 is a potent chloropyridine ester-derived inhibitor. -
BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020. -
BA2282 YH-53Summary: YH-53 is a potent inhibitor. -
BA2283 MM3122Summary: MM3122 is a selective inhibitor of type II transmembrane serine proteases. -
BA2284 BofutrelvirSummary: Bofutrelvir (FB2001) is a major protease inhibitor of SARS-CoV-2. -
BA2285 ArbemnifosbuvirSummary: Arbemnifosbuvir is a nucleovirus RdRp-associated nucleotide group transferase (NiRAN) nonstructural protein 12 (nsp12) interfering drug. -
BA2287 4-O-MethylbavachalconeSummary: 4'-O-Methylbavachalcone is a chalcone isolated from psoralen. -
BA2288 WU-04Summary: WU-04 is a non-covalent inhibitor of SARS-CoV-2 targeting the 3CLpro protein. -
BA2289 SSAA09E2Summary: SSAA09E2 is a novel replication inhibitor. -
BA2290 TKB245Summary: TKB245 is a potent inhibitor.

